Another possibility to explain the lack of association between cholinesterase inhibitor use and pacemaker insertion is that in the years following the approval of these drugs in the Canadian drug formulary, anecdotal cases have led to an increased awareness of the possible development of bradycardia and resulted in a more cautious approach to drug prescribing and symptom management. The gene discussed is BCHE; the disease is Bradycardia.